2012 Mar;97(3):E419-22
"As more weight-loss drugs enter the market, competition will intensify," Tricia Tan, consultant in metabolic medicine, endocrinology, and diabetes at Imperial College London, said in an accompanying article to the new data
According to a Health Canada approval announced by Novo Nordisk on March 2, 2026, the new indication is based on a pooled analysis of four large clinical trials: SUSTAIN 6, PIONEER 6, FLOW, and SOUL
Lucie, we proudly serve patients across the Treasure Coast, including Fort Pierce, Stuart, and nearby areas
This knowledge empowers patients to report any changes promptly and participate actively in their treatment plan
This article breaks down the real differences between injectable and sublingual CJC-1295 + Ipamorelin, and explains why the sublingual route has become the preferred option at TruHealth PT